Barber PA, Auer RN, Buchan AM, Sutherland GR. Understanding and managing ischemic stroke. Can J Physiol Pharmacol. 2001;79(3):283–96.PubMed

Barone FC, Tuma RF, Legos JJ, Erhardt JA, Parsons A. Brain inflammation, cytokines, and p38 MAP kinase signaling in stroke. In: Lin RCS, editor. New concepts in cerebral ischemia. Boca Raton: CRC; 2002.

Becker RC, Hochman JS, Cannon CP, Spencer FA, Ball SP, Rizzo MJ, Antman EM. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the thrombolysis and thrombin inhibition in myocardial infarction 9 study. J Am Coll Cardiol. 1999;33(2):479–87.PubMed

Bei W, Peng W, Zang L, Xie Z, Hu D, Xu A. Neuroprotective effects of a standardized extract of diospyros kaki leaves on MCAO transient focal cerebral ischemic rats and cultured neurons injured by glutamate or hypoxia. Planta Medica. 2007;73(7):636–43. doi:10.1055/s-2007-981532.PubMed

Chan PH, Kamii H, Yang G, Gafni J, Epstein CJ, Carlson E, Reola L. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport. 1993;5(3):293–6.PubMed

Chang RC, So KF. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell Mol Neurobiol. 2008;28(5):643–52. doi:10.1007/s10571-007-9181-x.PubMed

Cheng YD, Al-Khoury L, Zivin JA. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx. 2004;1(1):36–45. doi:10.1602/neurorx.1.1.36.PubMedCentralPubMed

Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391–7.PubMed

Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology. 2008;55(3):310–8. doi:10.1016/j.neuropharm.2008.01.005.PubMedCentralPubMed

Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: a guideline from the American heart association/American stroke association stroke council: cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group: the American academy of neurology affirms the value of this guideline. Stroke. 2006;37(6):1583–633. doi:10.1161/01.STR.0000223048.70103.F1.PubMed

Gong X, Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends Pharmacol Sci. 1999;20(5):191–6.PubMed

Group TNIoNDaSr-PSS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–7. doi:10.1056/NEJM199512143332401.

Hacke W, Brott T, Caplan L, Meier D, Fieschi C, von Kummer R, Donnan G, Heiss WD, Wahlgren NG, Spranger M, Boysen G, Marler JR. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology. 1999;53(7 Suppl. 4):S3–14.PubMed

He M, Pan H, Chang RC, So KF, Brecha NC, Pu M. Activation of the Nrf2/HO-1 antioxidant pathway contributes to the protective effects of Lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage. PloS ONE. 2014;9(1):e84800. doi:10.1371/journal.pone.0084800.PubMedCentralPubMed

Howes MJ, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytother Res. 2003;17(1):1–18. doi:10.1002/ptr.1280.PubMed